Next Article in Journal
Impact of Molecular Weight on Lymphatic Drainage of a Biopolymer-Based Imaging Agent
Previous Article in Journal / Special Issue
Ophthalmic Drug Delivery in Glaucoma—A Review
Article Menu

Export Article

Open AccessOther
Pharmaceutics 2012, 4(2), 252-275; doi:10.3390/pharmaceutics4020252

Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems

1
Heart Institute, Medical School Hospital, University of São Paulo, São Paulo 05403-000, Brazil
2
Faculty of Pharmaceutical Science, University of São Paulo, São Paulo 05508-000, Brazil
3
Department of Ophthalmology, University of Campinas, Campinas, São Paulo 13083-887, Brazil
*
Author to whom correspondence should be addressed.
Received: 8 February 2012 / Revised: 17 April 2012 / Accepted: 5 May 2012 / Published: 14 May 2012
(This article belongs to the Special Issue Ocular Drug Delivery)
View Full-Text   |   Download PDF [687 KB, 16 May 2012; original version 14 May 2012]   |  

Abstract

Several drug delivery systems have been proposed to overcome physiological barriers, improving ocular bioavailability. Systemic routes are seldom used due to the blood-ocular barrier. Novel drug delivery systems based on nanotechnology techniques have been developed to overcome ocular physiological barriers. This non-systematic review suggests the utilization of a transitory blood-ocular breakdown to allow the access of drugs by nanotechnology drug delivery systems via the systemic route. We discuss the possible ways to cause the breakdown of the blood-ocular barrier: acute inflammation caused by intraocular surgery, induced ocular hypotony, and the use of inflammatory mediators. The suitability of use of the systemic route and its toxic effects are also discussed in this article. View Full-Text
Keywords: blood-ocular barrier; hypotony; nanotechnology; ocular drug delivery system; ocular inflammatory mediators; systemic route blood-ocular barrier; hypotony; nanotechnology; ocular drug delivery system; ocular inflammatory mediators; systemic route
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Occhiutto, M.L.; Freitas, F.R.; Maranhao, R.C.; Costa, V.P. Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems. Pharmaceutics 2012, 4, 252-275.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top